Page 5 - Report From News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Milestone Pharmaceuticals Inc. recently announced positive Phase 2 data that show etripamil nasal spray resulted in rapid and statistically superior ventricular rate reduction and improved symptom-relief in patients with atrial fibrillation with rapid ventricular rate (AFib-RVR) compared to placebo. The findings were presented during the American Heart Association Scientific Sessions 2023, held recently in Philadephia, PA.

A team of researchers may have found a better treatment for one of the most common symptoms of long-term Covid: a chronically altered sense of smell. A

-- Analysis Also Found IPE Was Associated with a 41% Reduction in Total Events Compared with Placebo --

Etripamil, an investigational drug, showed statistically significant reduction in ventricular rate by 30 beats per minute for episodes of atrial fibrillation with rapid ventricular rate  compared to...

Abbott (NYSE: ABT), a global leader in heart health, announced today the Abbott HeartMates program, a new initiative that will kick off with professional football player Damar Hamlin as its first ambassador. Experiencing a major heart-related incident can cause emotional distress and be an incredibly isolating ...